FrancophonIA/ELRC3.0 huggingface dataset:
English: However, the Member States were not able to reach an agreement and the National Food Chain Safety Office of Hungary referred the matter to the CVMP for arbitration on 24 October 2014.
Danish: Medlemsstaterne var imidlertid ikke i stand til at nå til enighed, og Ungarns nationale fødevaresikkerhedsmyndighed indbragte sagen for CVMP til voldgift den 24. oktober 2014.
English: The product information for Coglapix in Hungary should also be amended.
Danish: Produktinformationen for Coglapix i Ungarn bør ligeledes ændres.
English: Duration of immunity was established for both serotypes (1 and 2) up to 16 weeks after vaccination according to the results of relevant challenge studies.
Danish: Immunitetens varighed blev for begge serotyper (1 og 2) bestemt op til 16 uger efter vaccinationen i henhold til resultaterne af relevante belastningsundersøgelser.
English: Ceva-Phylaxia Veterinary Biologicals Co. Ltd. submitted an application for Coglapix for mutual recognition on the basis of the initial authorisation granted by Hungary.
Danish: Ceva-Phylaxia Veterinary Biologicals Co. Ltd. har indsendt en ansøgning for Coglapix om gensidig anerkendelse på grundlag af den oprindelige godkendelse, der er udstedt af Ungarn.
English: The grounds for the referral were concerns raised by Italy that the efficacy of Coglapix has not been adequately demonstrated, that the benefit of the vaccine under practical conditions of use has not been demonstrated and that the results obtained from duration of immunity studies were inconsistent.
Danish: Begrundelsen for indbringelsen var Italiens betænkeligheder ved, at virkningen af Coglapix ikke var tilstrækkeligt påvist, at fordelen ved vaccinen under praktiske anvendelsesbetingelser ikke var påvist, og at resultaterne af undersøgelserne af immunitetens varighed var usammenhængende.
English: On 3 June 2015, the European Medicines Agency (the Agency) completed an arbitration procedure following a disagreement among Member States of the European Union (EU) regarding the authorisation of the medicine Coglapix suspension for injection for pigs.
Danish: Den 3. juni 2015 gennemførte Det Europæiske Lægemiddelagentur en voldgiftsprocedure efter en uoverensstemmelse blandt medlemsstaterne i Den Europæiske Union (EU) om godkendelsen af lægemidlet Coglapix, injektionsvæske, suspension, til svin.
English: Hence, the relevant sections of the Summary of Product Characteristics and package leaflet should be amended in order to reflect this.
Danish: De pågældende afsnit af produktresuméet og indlægssedlen bør derfor rettes, så dette fremgår.
English: The vaccine contains five formaldehyde-inactivated strains of Actinobacillus pleuropneumoniae.
Danish: Vaccinen indeholder fem formaldehyd-inaktiverede stammer af Actinobacillus pleuropneumoniae.
English: The CVMP also recommended that the product information for the medicine in Hungary be amended.
Danish: CVMP anbefalede desuden, at produktoplysningerne for lægemidlet i Ungarn rettes.
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Coglapix outweigh its risks, and the marketing authorisation granted in Hungary can be recognised in other Member States of the EU (see below).
Danish: Agenturets Udvalg for Lægemidler til Dyr (CVMP) konkluderede, at fordelene ved Coglapix opvejer risiciene, og at den markedsføringstilladelse, der er udstedt i Ungarn, kan anerkendes i de øvrige EU-medlemsstater (se nedenfor).
English: The vaccine is intended for active immunisation of pigs against pleuropneumonia caused by A. pleuropneumoniae serotypes 1 and 2, in order to reduce the clinical signs and lung lesions associated with the disease.
Danish: Vaccinen er bestemt til aktiv immunisering af svin mod pleuropneumoni forårsaget af A. pleuropneumoniae serotype 1 og 2 med henblik på mindskelse af de kliniske tegn og lungeforandringer, der er forbundet med sygdommen.
English: Therefore, based on evaluation of the currently available data and the scientific discussion within the Committee, the CVMP concluded that the benefits of Coglapix outweigh its risks, and recommended that the marketing authorisation be granted in all concerned Member States.
Danish: Efter vurdering af de foreliggende data og den videnskabelige drøftelse i udvalget konkluderede CVMP derfor, at fordelene ved Coglapix opvejer risiciene, og anbefalede, at der udstedes markedsføringstilladelse for Coglapix i alle berørte medlemsstater.
English: Coglapix is an inactivated bacterial vaccine against porcine actinobacillosis.
Danish: Coglapix er en inaktiveret bakteriel vaccine mod porcin actinobacillose.
English: Why was Coglapix suspension for injection for pigs reviewed?
Danish: Hvorfor blev Coglapix, injektionsvæske, suspension, til svin, vurderet igen?
English: Based on the data presented it was concluded that following vaccination of pigs with Coglapix reduction of clinical signs and lung lesions associated with the disease has been demonstrated in laboratory efficacy studies, although some concerns on the statistical significance of the results still remain.
Danish: På grundlag af de forelagte data blev det konkluderet, at der i laboratorieundersøgelser af virkningen af vaccination af svin med Coglapix er påvist reduktion af de kliniske tegn og lungeforandringer, som er forbundet med sygdommen.
English: What is Coglapix suspension for injection for pigs?
Danish: Hvad er Coglapix, injektionsvæske, suspension, til svin?
English: 10 vials (multidose: 10 doses)
Danish: 10 hætteglas (multidosis: 10 doser)
English: Immediate Packaging
Danish: Pakningsstørrelse
English: 10 vials (monodose)
Danish: 10 hætteglas (enkeltdosis)
English: 10785 Berlin Germany
Danish: 10785 Berlin
English: List of the names, pharmaceutical forms, strengths of the medicinal products, route of administration, marketing authorisation holders in the Member States
Danish: Fortegnelse Over Lægemidlernes Navne, Lægemiddelformer, Styrker, Indgivelsesvej, Indehavere Af Markedsføringstilladelser I Medlemsstaterne
English: A-1150 Vienna
Danish: A-1150 Vienna Austria
English: Floridsdorfer Hauptstraße 1, A-1210 Wien
Danish: Corporation Aus sdorfer Hauptstraße 1, 1210 Wien a
English: Vetenskapsvägen 10 191 90 Sollentuna, Sweden
Danish: 191 90 Sollentuna, Sweden
English: Coeur DéfenseTour A - La Défense 4 92931 PARIS LA DEFENSE Cedex
Danish: Coeur DéfenseTour A - La Défense 4 92931 PARIS LA DEFENSE
English: Boulevard de la Plaine 17 1050 Brussels Belgium
Danish: A. evard de la Plaine 1050 Brussels Belgium
English: Instituto Pasteur de Lisboa, S.A.
Danish: Instituto Pasteur d sboa, S.A.
English: Wyeth Whitehall Export GmbH Storchengasse 1
Danish: Wyeth Whitehall Export GmbH
English: Burgos, Km 23 - Desvío Algete Km 1
Danish: Algete Km 1
English: Wyeth Farma S.A.
Danish: Wyeth Farm a S.A.
English: G/VIAL
Danish: G/VIA
English: Infusion
Danish: Infusi
English: John Wyeth & Brother Limited (trading as Wyeth Pharmaceuticals) Huntercombe Lane South Taplow, Maidenhead, Berks, SL6 0PH United Kingdom
Danish: John Wyeth Limited (trading as Wyeth Pharmaceutical Huntercomb Taplow, Ma Berks, SL6 0PH United Kingdo
English: Berkshire SL6 0PH United Kingdom
Danish: Maidenhead Berkshire SL6 0PH United Kingdom
English: Rua Dr. António Loureiro Borges, 2
Danish: Rua Borges, 2
English: Pfizer Pharma GmbH Linkstr.
Danish: Tyskland harma GmbH Linkstr.
English: Stroupežnického 3191/17, 150 00 Praha Smíchov, Czech Republic
Danish: Tjekkiet ckého 3191/17, 0 Praha Smíchov public
English: Intravenous use 2 g piperacillinum / 0,25 g tazobactamum
Danish: 2 g piperacillinum / 0,25 g tazobactamum
English: Arquiparque - Miraflores 1495-131 ALGÉS Portugal
Danish: Arquiparqu 1495-131 A
English: TAZOCIN 2g/0.25g contains 2 active ingredients; piperacillin 2g and tazobactam 0.25g both present as sodium salts.
Danish: TAZOCIN 2 g/0,25 g indeholder 2 aktive stoffer; piperacillin 2 g og tazobactam 0,25g begge til stede som natriumsalt.
English: Via Nettunense, 90 Aprilia (LT), 04011, Italy
Danish: Via Nettunense, Aprilia (LT), 04011, Italy op sning ntravenøs nvendelse pipera Tazob
English: John Wyeth & Brother Limited (trading as Wyeth Pharmaceuticals) Huntercombe Lane South Taplow
Danish: John Wyeth & Broth Limited er (trading as Wyeth als) be Lane South
English: TAZOCIN 4,0g/0,5g pulveris injekciju vai infūziju šķīduma pagatavošanai
Danish: TAZOCIN 4,0g/0,5g pulveris injekciju vai fūziju šķīd pagatavošan
English: 28700 San Sebastián de los Reyes (Madrid)
Danish: 28700 San Sebastián d Reyes (Ma e los inyecta drid),
English: TAZOCIN 4,5 g prašek za raztopino za injiciranje ali infundiranje
Danish: ZOCIN 4,5 g prašek za raztopino za injiciranje ali anje
English: 4g piperacillin and 0.5g tazobactam (both present as sodium salts).
Danish: 4 g piperacillin og 0,5g tazobactam (begge til stede som natriumsalt).
English: TAZOCILLINE 4 g/500 mg, poudre pour solution pour perfusion
Danish: 4 g/500 mg, poudre pour solution pour perfusion
English: 2,085 g sodium piperacillin + 268,30 mg sodium tazobactam
Danish: 2,085 g Natriumpiperacillin + 268,30 mg natriumtazobactam
English: Sodium piperacillin and sodium tazobactam, equivalent to 4 g piperacillin and 500 mg tazobactam
Danish: Natriumpiperacillin og natriumtazobactam, svarende til 4 g piperacillin og 500 mg tazobactam
English: 4 g piperacillin equivalent to 4.17 g piperacillin sodium
Danish: 4,17 g natriumpiperacillin e til 4 g piperacillin
English: 4,170 g sodium piperacillin + 536,60 mg sodium tazobactam
Danish: 4,170 g natriumpiperacillin + 536,60 mg natriumtazobactam
English: Piperacillin (in the form of piperacillin sodium) 4 g Tazobactam (in the form of tazobactam sodium) 0.50 g
Danish: Piperacillin (i form af piperacillinnatrium) 4 g Tazobactam (i form af tazobactamnatrium) 0,50 g
English: 2g/0.25g
Danish: Tazocin2g/0.25g
English: TAZOCIN 4g/0.5g contains 2 active ingredients; piperacillin 4g and tazobactam 0.5g both present as sodium salts.
Danish: TAZOCIN 4 g/0,5 g indeholder 2 aktive stoffer; piperacillin 4 g og zobactam 0,5 g begge til stede som msalt.
English: 0.5366 g tazobactam sodium equivalent to 0.500 g tazobactam and 4.170 g piperacillin sodium equivalent to 4.00 g piperacillin
Danish: 0,5366 g tazobactamnatrium svarende til 0,500 g tazobactam og 4,170 g piperacillinnatrium svarende til 4,00 g piperacillin
English: Lyophilisate for injection or infusion
Danish: Lyofilisat til injektions- eller infusionsvæske
English: Pfizer S.A.
Danish: Pfizer S.
English: 2.00 g as piperacillin sodium and tazobactam 0.25 g as tazobactam sodium.
Danish: Piperacillin 2,00 g som piperacillinnatrium og tazobactam 0,25 g som tazobactamnatrium.
English: Piperacillin 2g and tazobactam250mg both present as sodium salts.
Danish: Piperacillin 4 g og tazobactam 500 mg begge til stede som natriumsalt.
English: Tazocel 2/0,25 g Polvo para solución inyectable
Danish: Tazocel 2/0,25 g Polvo para solución ble
English: Piperacillin
Danish: Piperaci
English: 4.5 G/VIAL
Danish: 4.5 G/V
English: Stroupežnického 3191/17, 150 00 Praha Smíchov Czech Republic
Danish: Stroupežn 150 00 Praha Czech Republic er til
English: Pfizer ApS Lautrupvang 8 2750 Ballerup Denmark
Danish: Lautrupvang 8 2750 Ballerup Denmark inf o sning tazobac svare 0,5 g
English: Piperacillin (in the form of piperacillin sodium) 2 g Tazobactam (in the form of tazobactam sodium) 0.25 g
Danish: Piperacillin (i form af piperacillinnatrium) 2 g azobactam (i form af obactamnatrium) 0,25 g taz
English: Powder for solution for infusion
Danish: LLIN solution pour perfusion
English: Pfizer AS Postboks 3
Danish: Pfizer AS Post
English: 4 g piperacillin (in form of piperacillin sodium) and 0,5 g tazobactam (in form of tazobactam sodium).
Danish: g piperacillin (i form af cillinnatrium) og 0,5 g ctam (i form af tazobactamnatrium).
English: 1 injection vial contains piperacillin sodium equivalent to 4.0g of piperacillin and tazobactam sodium equivalent to 0.5g of tazobactam.
Danish: 1 injektionshætteglas der peracillinnatrium svarende til 4,0 g piperacillin og tazobactamnatrium svarende til 0,5 g in ilisat til kt indehol pi tazobactam.
English: 2.085 g sodium piperacillin equivalent to 2 g piperacillin and 0.2683 g sodium tazobactam equivalent to 0.250 g tazobactam.
Danish: 2,085 g natriumpiperacillin svarende til 2 g piperacillin og 0,2683 g natriumtazobactam svarende til 0,250 g tazobactam.
English: 2.085 g of piperacillin sodium equivalent to 2 g of piperacillin and 0.2683 g of tazobactam sodium equivalent to 250 mg of tazobactam
Danish: 2,085 g piperacillinnatrium svarende til 2 g piperacillin og 0,2683 g ctamnatrium de til 250 mg tazobactam
English: Sodium piperacillin 2.085 g sodium tazobactam 268.300 mg
Danish: Piperacillinnatrium 2,085 g Tazobactamnatrium 0,2683 g
English: Sodium piperacillin 4.170 g sodium tazobactam 536.600 mg
Danish: Piperacillinnatrium 4,170 g Tazobactamnatrium 0,5366 g
English: Piperacillin sodium corresponding to piperacillin 2 g, tazobactam sodium corresponding to tazobactam.
Danish: Piperacillinnatrium svarende til piperacillin 2 g, tazobactamnatrium de til tazobactam
English: Intravenous use 4 g piperacillinum / 0,5 g tazobactamum
Danish: racillinum / 5 g tazobactamum
English: TAZOCIN 4g/0.5g Powder for Solution for Injection or Infusion
Danish: TAZOCIN 4g/0.5g Powder for Solution for
English: Tazocin® 2 g/ 250 mg 2g /250 mg Powder for solution for injection
Danish: Tazocin® 2 g/ 250 mg 2 g /
English: Sodium piperacillin and sodium tazobactam, equivalent to 2 g piperacillin and 250 mg tazobactam.
Danish: Pulver til je opløsning triumpiperacillin og mtazobactam, de til 2 g piperacillin og 250 mg tazobactam.
English: Powder for solution for injection and infusion Intravenous contains 4.170 g piperacillin sodium equivalent to 4g piperacillin and 0.5366 g tazobactam sodium equivalent to 500 milligrams tazobactam
Danish: Pulver til injektions/infusions væske, opløsning g piperacillinnatrium svarende til 4 g piperacillin og 0,5366 g tazobactamnatrium svarende til 500 milligram ctam.
English: 0,25 g
Danish: 6 0PH
English: 0.5 g tazobactam equivalent to 0.5366 g tazobactam sodium
Danish: 4000 mg piperacillin og 0,5366 g tazobactamnatrium
English: 4.170 g of piperacillin sodium equivalent to 4 g of piperacillin and 0.5366 g of tazobactam sodium equivalent to 500 mg of tazobactam
Danish: 4,170 g piperacillinnatrium svarende til 4 g piperacillin og 0,5366 g tazobactamnatrium svarende til 500 milligram tazobactam
English: Powder for solution for injection and infusion contains 2.085g piperacillin sodium equivalent to 2g piperacillin and 0.2683 g tazobactam sodium equivalent to 250 milligrams tazobactam
Danish: Tazocin 2,25g lve injektionsvæske/ infusionsvæske, opløsning der 2,085 g llinnatrium svarende piperacillin og 0,2683 g tazobactamnatrium
English: 4.170 g piperacillin sodium equivalent to 4 g piperacillin and 0.5366 g tazobactam sodium equivalent to 500 mg tazobactam.
Danish: 4,170 g piperacillinnatrium svarende til 4 g piperacillin og 0,5366 g azobactamnatrium rende til 500 mg zobactam.
English: Piperacillin sodium corresponding to piperacillin 4 g, tazobactam sodium corresponding to tazobactam 0,5 g
Danish: Lyofiliseret pulv ti jektionsvæ infusionsvæske, opløsning peracillin 4,00 g som peracillinnatrium og tazobactam 0,5 g som tamnatrium.
English: Lyophilised powder for solution for injection or infusion
Danish: Lyofiliseret pulver til injektionsvæske/ infusionsvæske, opløsning
English: Piperacillin sodium corresponding to piperacillin 4 g and tazobactam sodium corresponding to tazobactam 0,5 g
Danish: Piperacillinnatrium svarende iperacillin 4 g og tazobactamnatrium svarende til tazobactam 0,5 g
English: Tazocin 4g/500 mg poudre pour solution injectable
Danish: Tazocin 4g/500 mg ul er til in
English: to piperacillin 2g) 2085 mg Tazobactam sodium (equiv.
Danish: Piperacillinnatrium (sv. til acillin 2 g) 2085 mg actamnatrium (sv. til ctam250 mg) 3 mg
English: 2g/250mg Powder for solution for infusion
Danish: 0.25g Powder for Solution for
English: Powder for solution for injection or infusion.
Danish: Pulver til injektionsvæske/ infusionsvæske,
English: Intravenous (Infusion, Injection)
Danish: Injection or Infusion
English: Piperacillin.
Danish: ta natriu
English: (TAZOCIN 4 g/0,5 g powder for solution for injection/infusion Piperacillin/Tazobactam)
Danish: ЗОЦИНТМ 4 g/0,5 g инжекционе н разтвор цилин/Тазобак g/0,5 g pulver til injektions/infusionsvæ ske, opløsning acillin/T
English: Piperacillin sodium corresponding to piperacillin 2 g, tazobactam sodium corresponding to tazobactam 0,25 g.
Danish: racillinnatrium svarende til piperacillin 2 g, atrium svarende til tazobactam 5 g.
English: Pfizer Corporation Austria Ges.m.b.H
Danish: Pfizer Europe MA EE Ramsgate
English: This overview was last updated in 05-2018.
Danish: Denne oversigt blev sidst ajourført i 05-2018.
English: Ivemend received a marketing authorisation valid throughout the EU on 11 January 2008.
Danish: Ivemend fik markedsføringstilladelse med gyldighed i hele EU den 11. januar 2008.
English: Further information on Ivemend can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Yderligere information om Ivemend findes på agenturets websted under:: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This means that it is converted to aprepitant in the body.
Danish: Det betyder, at det omdannes til aprepitant i kroppen.
English: Other information about Ivemend
Danish: Andre oplysninger om Ivemend
English: An overview of Ivemend and why it is authorised in the EU
Danish: En oversigt over Ivemend, og hvorfor det er godkendt i EU
English: As for all medicines, data on the use of Ivemend are continuously monitored.
Danish: Som for alle lægemidler bliver data vedrørende brug af Ivemend løbende overvåget.
English: What measures are being taken to ensure the safe and effective use of Ivemend?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Ivemend?
English: Aprepitant has been authorised in the European Union (EU) as Emend since 2003.
Danish: Aprepitant har været godkendt i EU under navnet Emend siden 2003.
English: What is Ivemend and what is it used for?
Danish: Hvad er Ivemend, og hvad anvendes det til?
English: Why is Ivemend authorised in the EU?
Danish: Hvorfor er Ivemend godkendt i EU?
English: The European Medicines Agency therefore decided that Ivemend's benefits are greater than its risks and it can be authorised for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede derfor, at fordelene ved Ivemend opvejer risiciene, og at det kan godkendes til anvendelse i EU.
English: For more information about using Ivemend, see the package leaflet or contact your doctor or pharmacist.
Danish: For mere information om brug af Ivemend, se indlægssedlen eller kontakt lægen eller apotekspersonalet.
English: What are the risks associated with Ivemend?
Danish: Hvilke risici er der forbundet med Ivemend?
English: Aprepitant is a neurokinin 1 (NK1) receptor antagonist.
Danish: Aprepitant er en neurokinin 1 (NK1)-receptorantagonist.
English: It contains the active substance fosaprepitant.
Danish: Det indeholder det aktive stof fosaprepitant.
English: When substance P attaches to these receptors, it causes nausea and vomiting.
Danish: Når substans P binder til disse receptorer, udløser det kvalme og opkastning.
English: By blocking these receptors, Ivemend can prevent nausea and vomiting, which often happens during and after chemotherapy.
Danish: Ved at blokere for disse receptorer kan Ivemend forebygge den kvalme og opkastning, der ofte opstår under og efter kemoterapi.
English: Side effects reported with Ivemend are carefully evaluated and any necessary action taken to protect patients.
Danish: Indberettede bivirkninger ved Ivemend vurderes omhyggeligt, og der tages de nødvendige forholdsregler for at beskytte patienterne.
English: It stops a chemical in the body called ‘substance P' from attaching to the NK1 receptors.
Danish: Den forhindrer et kemisk stof i kroppen (substans P) i at binde til NK1-receptorerne.
English: The active substance in Ivemend, fosaprepitant, is a ‘prodrug' of aprepitant.
Danish: Det aktive stof i Ivemend, fosaprepitant, er et såkaldt prodrug for aprepitant.
English: In children it may be given on the first day or on multiple days through a tube inserted into a large vein near the heart.
Danish: Hos børn kan det gives på den første behandlingsdag eller over flere dage gennem et kateter, der anlægges i en stor vene (blodåre) tæt på hjertet.
English: Ivemend must always be given together with other medicines that prevent nausea and vomiting, including a corticosteroid (such as dexamethasone) and a ‘5HT3 antagonist' (such as ondansetron).
Danish: Ivemend skal altid gives sammen med andre lægemidler, som forebygger kvalme og opkastning, bl.a. et kortikosteroid (f.eks. dexamethason) og en såkaldt 5-HT3-antagonist (f.eks. ondansetron).
English: How is Ivemend used?
Danish: Hvordan anvendes Ivemend?
English: The most common side effects with Ivemend (seen in between 1 and 10 patients in 100) are increased liver enzymes, headache, hiccups, constipation, dyspepsia (heartburn), loss of appetite and fatigue (weakness or tiredness).
Danish: De hyppigste bivirkninger ved Ivemend (der kan forekomme hos mellem 1 og 10 ud af 100 patienter) er forhøjede leverenzymer, hovedpine, hikke, forstoppelse, fordøjelsesbesvær (halsbrand), appetitløshed og træthed eller mathed.
English: Ivemend must not be used at the same time as pimozide (used to treat mental illness), terfenadine and astemizole (used to treat allergy symptoms) and cisapride (used to relieve certain stomach problems).
Danish: Ivemend må ikke anvendes samtidig med pimozid (til behandling af psykiske lidelser), terfenadin og astemizol (til behandling af allergisymptomer) og cisaprid (til lindring af visse maveproblemer).
English: A main study in 2,000 patients with cancer showed that Ivemend was as effective as a Emend another medicine approved for preventing nausea and vomiting.
Danish: Et hovedstudie hos 2.000 kræftpatienter viste, at Ivemend var lige så effektivt som lægemidlet Emend til forebyggelse af kvalme og opkastning.
English: A main study showed that Ivemend was as effective as Emend at preventing nausea and vomiting in patients undergoing chemotherapy and its side effects are considered to be manageable.
Danish: En hovedundersøgelse viste, at Ivemend var lige så effektivt som Emend til forebyggelse af kvalme og opkastning hos patienter i behandling med kemoterapi, og bivirkningerne vurderes at være håndterbare.
English: What benefits of Ivemend have been shown in studies?
Danish: Hvilke fordele viser studierne, at der er ved Ivemend?
English: It is used in adults and children from 6 months of age who are undergoing chemotherapy known to cause moderate or severe nausea and vomiting.
Danish: Det anvendes hos voksne og børn i alderen 6 måneder og derover, som får kemoterapi, der giver moderat til svær kvalme og opkastning.
English: In adults, Ivemend is given as a slow infusion into a vein on the first day of chemotherapy.
Danish: Hos voksne gives Ivemend som en langsom infusion (drop) i en blodåre på den første behandlingsdag med kemoterapi.
English: Ivemend is a medicine for preventing nausea (feeling sick) and vomiting caused by chemotherapy cancer medicines.
Danish: Ivemend er et lægemiddel til forebyggelse af kvalme og opkastning, der skyldes kræftmedicin (kemoterapi).
English: For the full list of side effects reported with Ivemend, see the package leaflet.
Danish: Den fuldstændige liste over indberettede bivirkninger ved Ivemend fremgår af indlægssedlen.
English: Around 72% of patients treated with either medicine did not have any nausea or vomiting over the five days after receiving chemotherapy.
Danish: lægemidler, oplevede ingen kvalme eller opkastning i en periode på fem dage efter indgivelse af kemoterapi.
English: How does Ivemend work?
Danish: Hvordan virker Ivemend?